Literature DB >> 1547829

Cell selection strategies for making antibodies from variable gene libraries: trapping the memory pool.

R E Hawkins1, G Winter.   

Abstract

The B cells of immunized animals can be used as a source of variable region (V) gene libraries. Such libraries offer a way of making antibodies directly in bacteria: rearranged V genes are amplified using the polymerase chain reaction, cloned and expressed as soluble fragments in bacteria, and then screened for antigen binding. Here we have used a model system to investigate antigen-selected B cells as a source of V gene libraries. Mice were immunized with (4-hydroxyl-3-nitrophenyl)acetyl (NP)-chicken gammaglobulin, and the splenocytes harvested seven days after primary immunization. We prepared a heavy chain variable (VH) gene library from the DNA of cells selected on antigen-coated magnetic beads, and two other libraries from the DNA or mRNA of unselected cells. The VH gene libraries were combined with the V lambda 1 gene (as this light chain dominates the primary response to NP), expressed as Fv fragments in Escherichia coli and screened for binding to (4-hydroxy-3-iodo-5-nitrophenyl)acetyl-bovine serum albumin. The frequency of antigen-binding clones was much greater (greater than 50 fold) in the library from the DNA of antigen-selected cells (17/282) or from the mRNA of unselected cells (29/282) compared to the DNA from unselected cells (0/940). Sequencing of the antigen-binding clones revealed that they almost invariably used the V-186.2 heavy chain, as expected from analysis of primary response hybridomas. The D segments from the mRNA library were entirely DFL16.1 (29/29), as in primary response hybridomas, whereas those from the DNA of selected cells were more diverse, using in addition to DFL16.1, other D segments (5/17) as in later response hybridomas. This suggests that the DNA library from selected cells is derived at least in part from cells destined for the memory compartment. Given the long life of memory cells, they may prove a useful source of antibody libraries in the absence of recent immunization.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547829     DOI: 10.1002/eji.1830220336

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Adapting antibodies for clinical use.

Authors:  R E Hawkins; M B Llewelyn; S J Russell
Journal:  BMJ       Date:  1992-11-28

Review 2.  Bacteriophage epitope libraries. The generation of specific binding proteins and peptides in vitro.

Authors:  L M Fink; P L Hsu
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

3.  Engineered Antibody Fragments for Immunodiagnosis of Papaya ringspot virus.

Authors:  Yogita Maheshwari; H N Verma; R K Jain; Bikash Mandal
Journal:  Mol Biotechnol       Date:  2015-07       Impact factor: 2.695

4.  The rescue by phage display of human Fabs to gp120 HIV-1 glycoprotein using EBV transformed lymphocytes.

Authors:  E Kempf; E Weiss; P Klein; A Glacet; S Spratt; D Bourel; G Orfanoudakis
Journal:  Mol Biotechnol       Date:  2001-02       Impact factor: 2.695

5.  Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice.

Authors:  X Yang; J Stedra; J Cerny
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

6.  Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.

Authors:  Yan-Da Lai; Yen-Yu Wu; Yi-Jiue Tsai; Yi-San Tsai; Yu-Ying Lin; Szu-Liang Lai; Chao-Yang Huang; Ying-Yung Lok; Chih-Yung Hu; Jiann-Shiun Lai
Journal:  Int J Mol Sci       Date:  2016-02-05       Impact factor: 5.923

7.  Human anti-self antibodies with high specificity from phage display libraries.

Authors:  A D Griffiths; M Malmqvist; J D Marks; J M Bye; M J Embleton; J McCafferty; M Baier; K P Holliger; B D Gorick; N C Hughes-Jones
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

8.  In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells.

Authors:  J Jacob; J Przylepa; C Miller; G Kelsoe
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

9.  In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance.

Authors:  S Han; B Zheng; J Dal Porto; G Kelsoe
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.